Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialMolecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaCluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, AngolaSelection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.Monitoring antifolate resistance in intermittent preventive therapy for malaria.Intermittent preventive treatment of malaria in infants: how does it work and where will it work?A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal.
P2860
Q21032450-70E41C2B-2A99-4679-A44B-1A5EAAED9CBBQ28481649-290FE530-80BC-449D-AD52-E10758A3FEF1Q33645358-4015A4EF-D728-4E4C-824F-E34E5C320771Q33691573-32B85562-5D3D-4DFF-AA76-ED7489A2E689Q34576841-04E197C6-7928-40C0-9377-BC864D3B054AQ34596548-D070A933-AD0D-4CA2-B73B-0630BAA0CD6FQ35680383-89CFA0D2-0976-4E92-A444-D1326D3B08EDQ37035250-DDEB35FB-6CD9-4A60-94EE-9B7CBDB90F18Q37119559-F6F84AB3-5A4C-4EB2-9DE2-3D5849BBD7CCQ37260585-8366FD79-AC96-46D7-8882-D4ACFA7CC4A3Q37532595-7B568481-DC91-4BA2-9763-4D991255803EQ39345222-2DA96D12-3378-4263-8CD9-B7D9520994B6Q41157564-1AFDB32B-5455-4FF6-A84F-21542585C2C3Q47969205-823FA821-4E3D-4F4B-941E-DDE397B0AA34
P2860
Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Molecular markers of resistanc ...... malaria in Mozambican infants.
@en
Molecular markers of resistanc ...... malaria in Mozambican infants.
@nl
type
label
Molecular markers of resistanc ...... malaria in Mozambican infants.
@en
Molecular markers of resistanc ...... malaria in Mozambican infants.
@nl
prefLabel
Molecular markers of resistanc ...... malaria in Mozambican infants.
@en
Molecular markers of resistanc ...... malaria in Mozambican infants.
@nl
P2093
P50
P356
P1476
Molecular markers of resistanc ...... malaria in Mozambican infants.
@en
P2093
Agustín Benito
Alfredo Mayor
Carlota Dobaño
Clara Menéndez
Elisa Serra-Casas
Eusebio Macete
Jahit Sacarlal
Laura Puyol
Pedro Aide
Pedro Berzosa
P304
P356
10.1086/588144
P407
P577
2008-06-01T00:00:00Z